Nice 

Johnson & Johnson confirms opioid business has ended in $230 million settlement with New York

Johnson & Johnson has agreed to a $230 million settlement with New York state that bars the company
Johnson & Johnson confirms opioid business has ended in $230 million settlement with New York

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment1

  • Top
  • Latest
  • cjng85
    ·2021-06-28
    Good
    Reply
    Report